Free Access
Issue
Med Sci (Paris)
Volume 32, Number 11, Novembre 2016
Le microbiote : cet inconnu qui réside en nous
Page(s) 933 - 936
Section Le microbiote : cet inconnu qui réside en nous
DOI https://doi.org/10.1051/medsci/20163211007
Published online 23 December 2016
  1. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009 ; 31 : 677–689. [CrossRef] [PubMed] [Google Scholar]
  2. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010 ; 107 : 12204–12209. [CrossRef] [Google Scholar]
  3. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009 ; 15 : 1183–1189. [CrossRef] [PubMed] [Google Scholar]
  4. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008 ; 105 : 16731–16736. [CrossRef] [Google Scholar]
  5. Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut 2016 ; Feb 3. pii: gutjnl-2015-310746. doi: 10.1136/gutjnl-2015-310746. [Google Scholar]
  6. Liu TCC, Stappenbeck TS. Genetics and pathogenesis of inflammatory bowel disease. Annu Rev Pathol 2016 ; 11 : 127–148. [CrossRef] [PubMed] [Google Scholar]
  7. Lanternier F, Mahdaviani SA, Barbati E, et al. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. J Allergy Clin Immunol 2015 ; 135 : 1558–1568.e2. [CrossRef] [PubMed] [Google Scholar]
  8. Hsu YMSM, Zhang Y, You Y, et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 2007 ; 8 : 198–205. [CrossRef] [PubMed] [Google Scholar]
  9. Sokol H, Conway KL, Zhang M, et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 2013 ; 145 : 591–601.e3. [CrossRef] [PubMed] [Google Scholar]
  10. Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009 ; 206 : 1465–1472. [CrossRef] [PubMed] [Google Scholar]
  11. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011 ; 12 : 383–390. [CrossRef] [PubMed] [Google Scholar]
  12. Stelter C, Käppeli R, König C, et al. Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota. PLoS One 2011 ; 6 : e20749. [CrossRef] [PubMed] [Google Scholar]
  13. Lamas B, Richard ML, Leducq V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 2016 ; 22 : 598–605. [CrossRef] [PubMed] [Google Scholar]
  14. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells: a proposal for uniform nomenclature. Nat Rev Immunol 2013 ; 13 : 145–149. [CrossRef] [PubMed] [Google Scholar]
  15. Zelante T, Iannitti RG, Cunha C, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013 ; 39 : 372–385. [CrossRef] [PubMed] [Google Scholar]
  16. Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev 2013 ; 252 : 116–132. [CrossRef] [PubMed] [Google Scholar]
  17. Stockinger B, Di Meglio P, Gialitakis M, et al. The aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol 2014 ; 32 : 403–432. [CrossRef] [PubMed] [Google Scholar]
  18. Jin UHH, Lee SOO, Sridharan G, et al. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol Pharmacol 2014 ; 85 : 777–788. [CrossRef] [PubMed] [Google Scholar]
  19. Rahmouni O, Dubuquoy L, Desreumaux P, Neut C. Microbiote intestinal et développement des maladies inflammatoires chroniques de l’intestin. Med Sci (Paris) 2016 ; 32 : 968–973. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  20. Gaboriau-Routhiau V, Cerf-Bensussan N. Microbiote intestinal et développement du système immunitaire. Med Sci (Paris) 2016 ; 32 : 961–967. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  21. Le Chassaing B. microbiote intestinal, un acteur de la réponse immunitaire adaptative antivirale ?. Med Sci (Paris) 2015 ; 31 : 355–357. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.